Kodiak Sciences Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kodiak Sciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q3 2024.
  • Kodiak Sciences Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$46.6M, a 14.4% increase year-over-year.
  • Kodiak Sciences Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$204M, a 29.2% increase year-over-year.
  • Kodiak Sciences Inc. annual Operating Income (Loss) for 2023 was -$277M, a 18.8% increase from 2022.
  • Kodiak Sciences Inc. annual Operating Income (Loss) for 2022 was -$341M, a 27.8% decline from 2021.
  • Kodiak Sciences Inc. annual Operating Income (Loss) for 2021 was -$267M, a 96.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$204M -$46.6M +$7.87M +14.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$212M -$48M +$36.8M +43.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$249M -$46.1M +$28.6M +38.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$277M -$63.4M +$10.7M +14.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$288M -$54.5M +$25M +31.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$313M -$84.8M +$7.24M +7.86% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$320M -$74.6M +$21.2M +22.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$341M -$74.1M +$19M +20.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$360M -$79.5M -$11.9M -17.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$348M -$92.1M -$36.2M -64.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$312M -$95.8M -$45.2M -89.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$267M -$93M -$46.2M -98.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-01
Q3 2021 -$221M -$67.5M -$30.9M -84.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$190M -$55.9M -$29.1M -109% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$161M -$50.6M -$24.8M -96.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$136M -$46.8M -$30.7M -189% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$105M -$36.7M -$23.9M -188% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-01
Q2 2020 -$81.4M -$26.8M -$15M -127% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-01
Q1 2020 -$66.5M -$25.7M -$17.3M -204% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-01
Q4 2019 -$49.2M -$16.2M -$6.83M -73% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$42.4M -$12.7M -$6.35M -99.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$36M -$11.8M -$6.72M -132% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$29.3M -$8.46M -$2.91M -52.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$26.4M -$9.36M +$400K +4.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$26.8M -$6.38M -$2.4M -60.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$24.4M -$5.09M +$1.65M +24.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$26M -$5.55M -$504K -9.99% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$25.5M -$9.76M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-27
Q3 2017 -$3.98M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-27
Q2 2017 -$6.74M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-27
Q1 2017 -$5.04M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.